Characteristics | Overall(N = 251) | Previous(N = 178) | New(N = 73) | P |
---|---|---|---|---|
Age (year) | 61 ± 13 | 61 ± 12 | 59 ± 15 | 0.143 |
Male (%) | 133(53.0%) | 92(51.7%) | 41(56.2%) | 0.518 |
Dialysis age (month) | 37.27(3.33,117.32) | 73.23(34.69,134.17) | 0 | < 0.001 |
Primary disease (%) | Â | Â | Â | 0.173 |
 Glomerulonephritis | 87(34.7%) | 63(35.4%) | 24(32.9%) |  |
 Diabetes | 41(16.3%) | 21(11.8%) | 20(27.4%) |  |
 Hypertension | 39(15.5%) | 29(16.3%) | 10(13.7%) |  |
 Polycystic kidney | 27(10.8%) | 20(11.2%) | 7(9.6%) |  |
 Other | 57(22.7%) | 45(25.3%) | 12(16.4%) |  |
Comorbidity | ||||
 Diabetes mellitus | 55(21.9%) | 30(16.9%) | 15(34.2%) | 0.002 |
 Cardiovascular disease | 87(34.7%) | 61(34.3%) | 26(35.6%) | 0.839 |
 History of malignant tumor | 26(10.4%) | 19(10.7%) | 7(9.6%) | 0.798 |
Laboratory test | ||||
 Serum calcium (mmol/L) | 2.45 ± 0.15 | 2.46 ± 0.15 | 2.41 ± 0.17 | 0.21 |
 Serum phosphate (mmol/L) | 1.77 ± 0.38 | 1.79 ± 0.37 | 1.72 ± 0.40 | 0.075 |
 Serum iPTH (pg/ml) | 309.5 ± 167.8 | 311.9 ± 170.7 | 280.2 ± 134.6 | 0.773 |
 ALP (u/L) | 96.42 ± 71.26 | 100.65 ± 64.49 | 92.11 ± 85.19 | 0.181 |
 Hb (g/L) | 107.78 ± 11.81 | 108.73 ± 11.44 | 105.49 ± 12.43 | 0.07 |
 Alb (g/L) | 39.16 ± 3.36 | 38.85 ± 3.25 | 39.91 ± 3.54 | 0.008 |
 PAB (mg/L) | 292.99 ± 74.15 | 284.97 ± 73.23 | 312.46 ± 73.22 | 0.071 |
 hs-CRP (mg/L) | 4.25 ± 3.19 | 4.45 ± 3.56 | 4.04 ± 3.13 | 0.34 |
 NT-proBNP (pg/ml) | 5797(3025,16,474) | 7081(3441,18,204) | 3744(2631,8483) | 0.002 |
 nPCR | 1.13 ± 0.26 | 1.13 ± 0.25 | 1.12 ± 0.28 | 0.672 |
 spKt/V | 1.44 ± 0.29 | 1.46 ± 0.27 | 1.41 ± 0.31 | 0.169 |
 URR | 0.70 ± 0.08 | 0.70 ± 0.07 | 0.69 ± 0.09 | 0.29 |
 Total Phosphate-binding capacity | 88.23 ± 77.74 | 92.23 ± 58.42 | 83.91 ± 80.20 | 0.745 |
 Calcitriol (ug/week) | 0.75(0.00,1.88) | 0.75(0.00,2.15) | 0.75(0.00,1.25) | 0.16 |
 Cinacalcet | 20(8.0%) | 17(9.6%) | 3(4.1%) | 0.06 |